We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Amigo shares have rallied today! Here’s what I’d do now

Amigo shares rallied wildly today. Are they still worth buying? Anna Sokolidou thinks she knows the answer.

| More on:

You’re reading a free article with opinions that may differ from The Twelfth Magpie’s Premium Investing Services. Become a member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more, and get a free 'Best Buy Now' stock!.

Amigo (LSE:AMGO) shares rose by a staggering 15% today as of the time of writing. The question now is whether they are still worth buying.

Amigo earnings results

The surge is amazing if we analyse the recent news. Today the company reported its earnings for the three-month period ended on 30 June. Here’s the extract from Amigo’s press release

Should you buy Amigo Plc shares today?

Before you decide, please take a moment to review this report first. Despite ongoing uncertainties from US tariffs to global conflicts, Mark Rogers and his team believe many UK shares still trade at substantial discounts, offering savvy investors plenty of potential opportunities to learn about.

That’s why this could be an ideal time to secure this valuable research – Mark’s analysts have scoured the markets to reveal 5 of his favourite long-term ‘Buys’. Please, don’t make any big decisions before seeing them.

Source: Amigo Holdings

The company’s revenue plunged by almost a third compared to the same period a year ago. The earnings per share (EPS) fell by 84%. The only positive I can see here is that the efficiency indicator (operating cost/income ratio) went down.

At the same time, the poor results reported today are more than explainable. According to the company’s own definition, “Amigo is a leading provider of guarantor loans in the UK and offers access to mid‐cost credit to those who are unable to borrow from traditional lenders due to their credit histories”.  In plain terms, it lends money to individuals who are at higher risk of being unable to repay it.

The borrowing costs for such clients tend to be extremely high. Although such businesses are very profitable during good times, they tend to lose a lot during hard times. The Covid-19-related recession we are in now is a perfect example of hard times for such businesses. As we all understand, many people lose their jobs and cannot repay their debts. What’s more, Amigo often lends to people who want to travel but cannot afford to. The coronavirus lockdown was a catastrophe for the travel industry in general. Amigo suffered too. The company even links the dramatic sales revenue reduction to the Covid-19 impact. 

The Amigo share price surge

These results were horrible at first sight. It doesn’t seem logical that Amigo stock has surged. As can be seen from the graph below, the shares surged straight after the announcement. In my view, that’s because the market had already priced in a bad scenario. So, buying the stock after a weak earnings report might have looked like a smart move to many investors. 

Source: Google Finance 

As we can see from the histrical data above, Amigo shares are highly volatile. The 52-week high of 130p is almost 27 times higher than the stock’s 52-week low of 4.84p. This alone makes investing in the company look quite risky to me. Indeed, it looks like investors can gain a lot. At the same time, they can lose a lot too. 

Would I buy Amigo shares?

The key question here is what the future holds in store for Amigo. Moody’s rates the company as B3. In other words, the company has a ‘highly speculative’ credit rating. The agency notes that there is hardly any lending activity going on amid the pandemic. So, Amigo’s earnings and revenues will carry on declining until the economic situation gets much better. What’s more, the company also has to deal with a number of customer complaints, as ordered by the Financial Conduct Authority. All that poses significant risks to Amigo. But my colleague Rupert thinks that the business is “setting itself back on track”. Indeed, it still has a substantial cash pile. Although I think Amigo will survive the crisis, it’s still a risky stock. But patient and brave investors might achieve great returns if they buy some Amigo shares.

Anna Sokolidou has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

This way, That way, The other way - pointing in different directions
Investing Articles

Investec vs Aberdeen: which is the better income stock to buy?

Aiming to boost the average yield of his income portfolio, Mark Hartley's looking for new income stocks to buy on…

Read more »

Asian man looking concerned while studying paperwork at his desk in an office
Investing Articles

Down 41% since January, this quality S&P 500 stock is stinking out my ISA

The tide's turned against this S&P 500 robotics stock. Is it time to dump it? Or is there a no-brainer…

Read more »

GSK scientist holding lab syringe
Investing Articles

By mid-2027, analysts expect £6,000 in GSK shares to be worth…

GSK shares are currently trading almost 20% below their 2026 highs. Is there potential for a rebound over the next…

Read more »

Rolls-Royce's Pearl 10X engine series
Investing Articles

Up nearly 1,400% in 5 years! But are Rolls-Royce shares still secretly undervalued?

After skyrocketing, Rolls-Royce shares are now near an all-time high, but could the engineering giant still have more room to…

Read more »

Happy senior couple hugging and enjoying retirement at home
Investing Articles

By mid-2027, analysts expect £5,000 in Barclays shares to be worth…

Barclays shares have outperformed the FTSE 100 by a wide margin over the last year. And City analysts expect to…

Read more »

Man hanging in the balance over a log at seaside in Scotland
Investing Articles

Near 5-year lows, here’s what the experts say about the Diageo share price

Ben McPoland's questioning his sanity after investing in Diageo. Where do institutional analysts see its share price heading over the…

Read more »

British Airways cabin crew with mobile device
Investing Articles

Up 165% but still with a P/E of 7.9. Is the IAG share price a generational bargain?

The IAG share price has been on fire for the last two years, delivering some of the biggest returns in…

Read more »

Emma Raducanu for Vodafone billboard animation at Piccadilly Circus, London
Investing Articles

Here’s the latest Vodafone share price forecasts for 2027

Up 35% in 12 months, the Vodafone share price is beating the stock market right now, but can this momentum…

Read more »